Why is longevity still a scientific mystery? Sirtuins—past, present and future

P Ziętara, M Dziewięcka, M Augustyniak - International Journal of …, 2022 - mdpi.com
The sirtuin system consists of seven highly conserved regulatory enzymes responsible for
metabolism, antioxidant protection, and cell cycle regulation. The great interest in sirtuins is …

Sirtuin1-p53: A potential axis for cancer therapy

J Yin, X Lu, M Hou, T Cao, Z Tian - Biochemical pharmacology, 2023 - Elsevier
Abstract Sirtuin1 (SIRT1) is a conserved nicotinamide adenine dinucleotide (NAD+)-
dependent histone deacetylase that plays key roles in a range of cellular events, including …

Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies

A Wawruszak, J Luszczki, D Bartuzi… - Journal of Enzyme …, 2025 - Taylor & Francis
Abstract Sirtuins (SIRTs) are NAD+-dependent histone deacetylases, which play a key role
in cancer progression; however, their prognostic values in breast cancer (BC) remain a …

Advancements in understanding the role and mechanism of sirtuin family (SIRT1-7) in breast cancer management

D Sharma, M Panchaksaram, R Muniyan - Biochemical Pharmacology, 2025 - Elsevier
Breast cancer (BC) is the most prevalent type of cancer in women worldwide and it is
classified into a few distinct molecular subtypes based on the expression of growth factor …

Small-molecule inhibitor of Fam20C in combination with paclitaxel suppresses tumor growth by LIF-JAK2/STAT3-modulated apoptosis in triple-negative breast cancer

Z Yuan, Y Zhen, S Chen, Z Li, L Fu - Journal of the Taiwan Institute of …, 2023 - Elsevier
Background Triple negative breast cancer (TNBC) is a strongly proliferative, relapse prone,
high-mortality subtype of breast cancer. Due to the lack of effective therapeutic targets, the …

Isobolographic analysis of interactions–a pre-clinical perspective

JJ Łuszczki, A Wlaź - Journal of Pre-Clinical and Clinical Research, 2023 - jpccr.eu
Isobolographic analysis of interactions – a pre-clinical perspective Page 1 www.jpccr.eu CASE
STUDY Isobolographic analysis of interactions – a pre-clinical perspective Jarogniew J …

The Impact of Simultaneous Epigenetic and Epitranscriptomic Intervention in Breast Cancer Cells

S Yanar, AD Özkan, MGB Albayrak… - Istanbul Gelisim University …, 2024 - dergipark.org.tr
Aim: Breast cancer remains a significant cause of mortality worldwide, necessitating the
development of innovative therapeutic approaches. Epigenetic and epitranscriptomic …